Thursday, Oct 9, 2025 · SEC filings

What the smart money revealed on Oct 9

Real insider buys27insiders · $15.8M
Real insider sales19insiders · $47M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

154 insider filings came in. We hid 29 planned (10b5-1) sellers and 60 people whose filings were routine, like grants and tax withholding.

group

5 insiders at CPS Technologies (CPSH) bought $201K of stock

Roles: CEO, CFO, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Oct 8
$201K
group

3 insiders at Zenas BioPharma (ZBIO) bought $11.8M of stock

Roles: Officer, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Oct 7
$11.8M
trending_up

Agree Realty (ADC) Director John Rakolta bought $1.77M

25,154 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 6 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 4 of 6 beat Traded Oct 7
$1.77M
trending_up

aTYR Pharma INC (ATYR) Director Paul Schimmel bought $913K

1M shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Oct 8–9
$913K
trending_up

Zivo Bioscience (ZIVO) Director Christopher Maggiore bought $284K

23,682 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Oct 8
$284K
trending_up

Conagra Brands (CAG) Director Thomas Brown bought $187K

10,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Oct 7
$187K
trending_down

Strategy (MSTR) EVP & General Counsel Wei-Ming Shao sold $10.7M

Not marked as a planned 10b5-1 sale. Sold 70% of the shares they held directly. Still holds 12,726 shares.

Real sale Form 4 Sold 70% of stake Traded Oct 7
$10.7M
trending_down

SailPoint (SAIL) CEO Mark McClain sold $10.5M

Not marked as a planned 10b5-1 sale. Sold 6% of the shares they held directly. Still holds 7.2M shares.

Real sale Form 4 Traded Oct 7–9
$10.5M
trending_down

Disc Medicine (IRON) Director Kevin Bitterman sold $6.31M

Not marked as a planned 10b5-1 sale. Sold 15% of the shares they held directly. Still holds 500,621 shares.

Real sale Form 4 Traded Oct 7–8
$6.31M
Show 15 more real buys
Show 16 more real sales

13F season

Holdings as of Sep 30, 2025 are due Nov 14

81 funds have filed so far. 74 filed for the quarter before.

Biggest real insider buys, Oct 3–9

Open-market buys by officers and directors, filed in the 7 days up to Oct 9.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist